Syngene International

The ‘China Plus One’ gold rush: 3 Indian pharma stocks making the most of it

India’s CDMO sector is rapidly expanding, driven by global pharma’s shift away from China, strong regulatory compliance, cost-efficiency, and government…

September 5, 2025 05:30 IST

Norges Bank, the central bank of Norway is responsible for managing the Government Pension Fund of Norway. It is the world's largest sovereign wealth fund. (Image Source: Wikipedia)

5 Indian stocks the world’s largest wealth fund raised stakes in

The world’s largest sovereign wealth fund that manages over US$ 1 Trillion in assets and that made profits of US$222…

Updated: June 11, 2025 15:04 IST

indian pharma stock price, pharmacueticals

Will Indian pharma withstand the Trump administration?

Investors are closely monitoring the performance of Indian pharma companies in the March 2025 quarter and their ability to grow…

May 14, 2025 05:30 IST

Protean eGov Technologies share price, PAN 2.0 project

Syngene International shares plummet 13%: Here’s what’s worrying investors

Syngene share price today, April 24: Syngene’s stock drops 13% due to 8% Q4 profit decline. Explore insights into their…

April 24, 2025 14:22 IST

Kotak Institutional recommends Buy on these 3 stocks at this hour

Kotak Institutional Equities recommends Piramal Pharma, Syngene International, and Indegene as top buys, citing strong growth potential in CRDMOs, pharmaceutical…

March 27, 2025 17:26 IST

stocks to watch, stock in news, stocks in news

Stocks To Watch: From Godrej Consumer to IndusInd Bank- Here’s a list of 7 stocks in news today

Stocks to watch today, March 11: GIFT Nifty was trading lower at 22,363, which indicates a negative start for domestic…

March 11, 2025 07:27 IST

Biocon, generic API business, divestment options, debt, investment banks, pricing pressures, Generic Formulations

Biocon’s Syngene to invest Rs 788 Crore for campus expansion in Genome Valley, Hyderabad

Reportedly, the company has plans to inject Rs 788 crore and create 1,000 additional jobs in the project over the…

September 15, 2023 09:04 IST

Rare Diseases, Ministry of Health, Ministry of Finance, Rare Diseases Treatment, Custom Duty, Healthcare news,

Syngene International’s consolidated net profit rises 5.48%; Revenue up to Rs. 803 crores

Hunt said that in Manufacturing, the highlight of the quarter was the successful inspection of our biologics facilities by the…

January 24, 2023 13:30 IST

Syngene, revenue, health news, healthcare news,

Syngene reports revenue from operations up 8 percent in first quarter

The first quarter results were against a strong quarter last year due to sales of COVID treatment, Remdesivir. Excluding the…

July 20, 2022 18:52 IST

Nifty Pharma index nearly doubles since March; 3 pharma stocks set to rally up to 45%

Macquaries sees Divi’s Laboratories and Syngene International as well placed in terms of growth, margin profile and return ratios

October 8, 2020 15:47 IST

Syngene delivers sustained growth in Q4 FY16

Revenue grows 31 per cent to Rs 334 crore; EBITA up by 23 per cent to Rs 106 crore

April 27, 2016 10:18 IST

Rallis India, NHPC, Bharti Infratel among 11 stocks that remained in focus today

Raymond stocks closed 5.07 per cent up at Rs 418.80 after it reported over twofold jump in consolidated net profit…

Updated: April 27, 2016 17:13 IST

Biocon shares fall post Q3 results, Syngene International gains over 7%

Biocon’s contract research arm Syngene International on Thursday reported 31.25 per cent rise in net profit to Rs 58.8 crore…

Updated: January 22, 2016 16:25 IST

Syngene appoints Jonathan Hunt as CEO-designate

Hunt will be responsible for strengthening Syngene’s relations with its existing global customers

January 20, 2016 15:45 IST

Top 5 stocks on market in ‘singles’ category: Talwalkars Better Value Fitness to SKS Microfinance

After the success of Dr Lal PathLabs IPO and subsequent listing, we take a look at some companies which are…

December 28, 2015 12:50 IST

Alone and loving it: Lal Pathlabs and five other stock singles

After the success of Dr Lal Pathlabs, we take a look at some companies which are the only listed ones…

Updated: December 23, 2015 16:20 IST

Syngene to spend $100 m on new plant at Mangalore SEZ

Syngene International, a contract research arm of biotech major Biocon, has firmed up plans to diversify into contract manufacturing.

August 29, 2015 03:40 IST

Syngene International IPO oversubscribed 31 times

The IPO is an offer for sale (OFS) by Biocon of a part of its shareholding in Syngene Syngene International’s…

July 30, 2015 09:16 IST

Related News

Aadhaar Card update October 2025: Here's how to change name, address, date of birth and phone number online in simple steps

Aadhaar Card new update October 2025: Here’s how to change name, address, date of birth and phone number online in simple steps

Aadhaar rule change 2025: New UIDAI update fees, PAN-Aadhaar link and KYC rules explained

Aadhaar rule change 2025: New UIDAI update fees, PAN-Aadhaar linking and KYC rules explained

EPFO’s pension rules: 5 major changes for EPS account holders – find out what’s new

Smart Investor’s Guide to Safe Investing Online

Green card holders, 2025 Naturalization Civics Test full list, 2025 civics test, U.S. citizenship, naturalization process, US immigration policy, new naturalization civics test 2025, USCIS 2025 citizenship test

US announces 2025 civics test for green card holders starting today

India’s core sector growth rises to 3% in September, up 0.6% YoY

Business1 hr ago

India’s core infrastructure sectors’ growth rate increased by 3% in September 2025, according to official data from the Ministry of Commerce & Industry. This is a significant improvement from the previous year’s growth rate of 2.4%. However, the overall growth for April-September of this fiscal year was 2.9%, lower than the previous year’s 4.3% growth.

View all shorts